Key Metrics of Glaukos
Revenue$315M▲ 11.3% YoYFY 2023
Operating income−$129M▼ 56.4% YoY
Net profit−$135M▼ 35.8% YoY
Shareholders' equity$462M
Market cap$10.4BGKOS · $176.69
About Glaukos
Company details
- Website
- glaukos.com
- Founded
- 2015
- Listed
- NYSE: GKOS (since 2015)
Company summary
Legal nameGlaukos Corporation
TickerGKOS
ExchangeNYSE
CountryUnited States
SEC CIK0001192448
Listed since2015
IndustryMedical/Dental Instruments
SectorOther Industries · Discovered Companies
Websitehttp://www.glaukos.com
US market & SEC filings
GKOS · NYSE · SEC CIK 0001192448
Last price · 24 Oct 2026
$176.69
−0.09%
Market cap$10.4B
P/E—On FY 2023 diluted EPS
Volume885,823
SectorHealth CareMedical/Dental Instruments
Country · IPOUnited StatesListed 2015
GKOS share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered officeLaguna Hills
GSTIN—
Email—
Websitehttp://www.glaukos.com
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.
Filings
No filings on record yet.